4
Incorporated in 2008, Birla Pacific Medspa Limited is an India based healthcare provider. Birla Pacific Medspa is a  joint venture of Yash Birla Group, a Rs 30 billion group of over 20 diversified companies and Pacific Healthcare, East  Asia¶s leading healthcare provider, with healthcare facilities in Singapore, Hong Kong, and China. Birla Pacific Medspa provides beauty related medical procedures in India. Using state-of-the-art equipments, the internationally qualified panel of doctors provides patient centric solutions and offers the latest and safest treatments. Company operates it healthcare centers under the brand name EVOLVE. Company operates 3 healthcare centers in Mumbai and has 2 franchises in Thane and Chennai. Company's expertise includes Cosmetic Dermatology, Cosmetic & Plastic Surgery, General & Specialist Dentistry and Maxillo Facial Prosthesis. It has introduced i-lipo, a non-surgical inch loss treatment, for the first time in India. Company Promoters: Company is promoted by Mr. Yashovardhan Birla and one of his group companies, Birla Wellness & Healthcare Private Limited. Objects of the Issue: The objects of the issue are 1. To meet the capital expenditure towards establishing 55 outlets of Evolve Medspa across various cities and places. 2. To meet expenses towards brand promotion. 3. To meet the working capital requirements for running the centers. 4. To meet Issue related expenses. 5. To enlist the Company's Shares on Bombay Stock Exchange Limited (BSE).  Issue Detail: »» Issue Open: Jun 20, 2011 - Jun 23, 2011 »» Issue Type: 100% Book Built Issue IPO »» Issue Size: 65,175,000 Equity Shares of Rs. 10 »» Issue Size: Rs. 65.18 Crore »» Face Value: Rs. 10 Per Equity Share »» Issue Price: Rs. 10 - Rs. 11 Per Equity Share »» Market Lot: 500 Shares »» Minimum Order Quantity: 500 Shares »» Listing At: BSE Birla Pacific Medspa Ltd IPO Grading BWR (Brickworks Ratings India Pvt Ltd) has assigned an IPO Grade 2 to Birla Pacific Medspa IPO. This means as per BWR, company has ' Below Average Fundamentals'. BWR assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Read Birla Pacific Medspa IPO Grading Report Issue Subscription Detail / Current Bidding Status Number of Times Issue is Subscribed (BSE + NSE)  As on Date & Time Qualified Institutional Buyers (QIBs) Non Institutional Investors (NIIs) Retail Individual Investors (RIIs) Total Shares Offered / Reserved 32,587,500 9,776,250 22,811,250 65,175,000 Day 1 - Jun 20, 2011 17:00 IST 0.3300 0.0000 0.2500 0.2500 Day 2 - Jun 21, 2011 17:00 IST 0.6700 0.0000 0.3700 0.4600 Day 3 - Jun 22, 2011 17:00 IST 0.9900 0.0000 0.5800 0. 7000 Day 4 - Jun 23, 2011 17:00 IST 1.0400 0.1700 1.8200 1.1800

Birla Medspa

Embed Size (px)

Citation preview

Page 1: Birla Medspa

8/6/2019 Birla Medspa

http://slidepdf.com/reader/full/birla-medspa 1/4

Incorporated in 2008, Birla Pacific Medspa Limited is an India based healthcare provider. Birla Pacific Medspa is a joint venture of Yash Birla Group, a Rs 30 billion group of over 20 diversified companies and Pacific Healthcare, East Asia¶s leading healthcare provider, with healthcare facilities in Singapore, Hong Kong, and China.

Birla Pacific Medspa provides beauty related medical procedures in India. Using state-of-the-art equipments, theinternationally qualified panel of doctors provides patient centric solutions and offers the latest and safest treatments.

Company operates it healthcare centers under the brand name EVOLVE. Company operates 3 healthcare centers inMumbai and has 2 franchises in Thane and Chennai. Company's expertise includes Cosmetic Dermatology,Cosmetic & Plastic Surgery, General & Specialist Dentistry and Maxillo Facial Prosthesis. It has introduced i-lipo, anon-surgical inch loss treatment, for the first time in India.

Company Promoters:

Company is promoted by Mr. Yashovardhan Birla and one of his group companies, Birla Wellness & HealthcarePrivate Limited.

Objects of the Issue: The objects of the issue are 1. To meet the capital expenditure towards establishing 55 outlets of Evolve Medspa across various cities and places.

2. To meet expenses towards brand promotion.3. To meet the working capital requirements for running the centers.4. To meet Issue related expenses.5. To enlist the Company's Shares on Bombay Stock Exchange Limited (BSE).  Issue Detail:

»» Issue Open: Jun 20, 2011 - Jun 23, 2011 »» Issue Type: 100% Book Built Issue IPO»» Issue Size: 65,175,000 Equity Shares of Rs. 10»» Issue Size: Rs. 65.18 Crore»» Face Value: Rs. 10 Per Equity Share»» Issue Price: Rs. 10 - Rs. 11 Per Equity Share»» Market Lot: 500 Shares

»» Minimum Order Quantity: 500 Shares»» Listing At: BSE

Birla Pacific Medspa Ltd IPO Grading

BWR (Brickworks Ratings India Pvt Ltd) has assigned an IPO Grade 2 to Birla Pacific Medspa IPO. This means asper BWR, company has 'Below Average Fundamentals'. BWR assigns IPO grading on a scale of 5 to 1, with Grade5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Read Birla Pacific Medspa IPO GradingReport

Issue Subscription Detail / Current Bidding Status

Number of Times Issue is Subscribed (BSE + NSE) 

As on Date & Time 

Qualified

Institutional

Buyers (QIBs) 

Non

Institutional

Investors (NIIs) 

Retail

Individual

Investors (RIIs) 

Total 

Shares Offered / Reserved 32,587,500 9,776,250 22,811,250 65,175,000

Day 1 - Jun 20, 2011 17:00 IST 0.3300 0.0000 0.2500 0.2500

Day 2 - Jun 21, 2011 17:00 IST 0.6700 0.0000 0.3700 0.4600

Day 3 - Jun 22, 2011 17:00 IST 0.9900 0.0000 0.5800 0.7000

Day 4 - Jun 23, 2011 17:00 IST 1.0400 0.1700 1.8200 1.1800

Page 2: Birla Medspa

8/6/2019 Birla Medspa

http://slidepdf.com/reader/full/birla-medspa 2/4

Birla Pacific Medspa Limited 

THE YASH BIRLA GROUP

Our company was originally Incorporated in the name of 'Birla Pacific Medspa Priavte Limited.' on July 15,2008 under the Companies Act, 1956 in the State of Maharashtra. The company was converted to a Public Company and the

name was consequently changed to 'Birla Pacific Medspa Limited' and a fresh Certificate of Incorporation consequentto Change of Name was obtained from Registrar of Companies, Maharashtra on 14th July, 2010. The CorporateIdentification Number of our Company is U85100MH2008PLC184689.

The Company is promoted by Mr. Yashovardhan Birla and Birla Wellness & Healthcare Pvt. Limited, a YashBirla Group company.

BASIS OF ALLOTMENT 

PUBLIC ISSUE OF 65,175,000 EQUITY SHARES OF RS.10/- EACH AT A PRICE OF RS. 10/- PER EQUITYSHARE FOR CASH AGGREGATING TO RS. 6517.50 LACS (THE "ISSUE"), BY BIRLA PACIFIC MEDSPALIMITED (THE "COMPANY" OR THE "ISSUER"). THE ISSUE CONSTITUTES 58.12% OF THE FULLY DILUTEDPOST ISSUE PAID-UP CAPITAL OF OUR COMPANY.

THE ISSUE PRICE IS ONE TIME OF THE FACE VALUEThe equity shares of the Company are proposed to be listed on Bombay Stock Exchange Limited

("BSE") and Trading is expected to commence on 7th july 2011

ISSUE PRICE: RS. 10/- PER EQUITY SHARE OF THE FACE VALUE OF RS. 10/- EACH 

BID/ISSUE OPENED ON JUNE 20, 2011 CLOSED ON JUNE 23, 2011 

This Issue was made through a 100% Book Building Process in terms of regulation 26(2)(a)(i) and b(i) of SEBI(ICDR) Regulations, 2009, as amended from time to time, whereby at least 50% of the Issue was to be allocated toQualified Institutional Buyers (QIBs) on a proportionate basis, subject to valid bids being received at or above theIssue Price. 5% of the QIB Portion was available for allocation on proportionate basis to Mutual Funds only and the

remaining Net QIB portion was available for allocation on a proportionate basis to all Qualified Institutional Buyers,including Mutual Funds, subject to valid bids being received at or above Issue Price. Further, upto 15% of the Issuewas available for allocation on a proportionate basis to Non Institutional Bidders and upto 35% of the Issue wasavailable for allocation on a proportionate basis to Retail Individual Bidders, subject to valid bids being received at or above the Issue Price.The Issue received 3138 applications for 74670000 equity shares resulting in 1.15 times subscription. The details of the applications received in the Issue from Qualified Institutional Buyers, Non-Institutional and Retail IndividualInvestor categories are as under: (Before technical rejections) 

Category  No. of Applications  No. of Shares  No. of times Subscription 

A Qualified Institutional Investors 5 33812000 1.03

B Non Institutional Investors 5 1614000 0.16

C Retail Individual Investors 3128 39244000 1.72

Total  3138  74670000  1.15 

Final Demand  A summary of the final demand as per BSE and NSE as on the Bid/Issue Closing date at different bid prices is asunder:

Bid Price  No. of Shares  % to Total  Cumulative Total  Cumulative % to Total 

10 32819500 42.58 77071000 100.00

11 6674000 8.66 44251500 57.42

Page 3: Birla Medspa

8/6/2019 Birla Medspa

http://slidepdf.com/reader/full/birla-medspa 3/4

Cutoff 37577500 48.76 37577500 48.76

Total  77071000  100 

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being The Bombay StockExchange Limited ("BSE") on June 30,2011 The Board of Directors of the Company at its Meeting held at Mumbai, on June 30,2011 allotted the Equity Shares to

the successful applicants. Details of valid applications received & allotments done are as under:

A. Allotment to Retail Individual Investors, including ASBA applications (After Technical Rejections) The Basis of Allotment to the Retail Individual Investors, who have bid at cut-off or at the Issue Price of Rs. 10/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 1.26 times. As per theProspectus, the spill over portion from QIB Category was 3591228 equity shares and 3346522 from Non InstitutionalCategory. The total number of equity shares allotted in this category is 29750366 Equity Shares (including 1366excess shares allotted for rounding off) to 2966 successful applicants. Out of the valid SCSB ASBA applications,8910549 equity shares were allotted to 1057 successful SCSB ASBA applicants. Out of the valid Syndicate ASBAapplications, 226626 equity shares were allotted to 18 successful Syndicate ASBA applicants. The category-wisedetails of the Basis of Allotment are as under:

Category No. of 

Applications % toTotal 

SharesApplied 

% toTotal 

No. of Sharesallocated 

Ratio Total No. of Shares

allocated 

500 524 16.96 262000 0.67 500 29:38 200000

1000 199 6.44 199000 0.51  763 1:1  151837 

1500 36 1.17 54000 0.14 1145 1:1 41220

2000 37  1.20 74000 0.19 1526 1:1 56462

2500 13 0.42 32500 0.08 1908 1:1 24804

3000 10 0.32 30000 0.08 2289 1:1 22890

3500 2 0.06 7000 0.02 2671  1:1 5342

4000 5 0.16 20000 0.05 3052 1:1  15260

4500 21 0.68 94500 0.24 3434 1:1  72114

5000 17 0.55 85000 0.22 3815 1:1 64855

5500 1 0.03 5500 0.01 4197  1:1 4197 

60001

0.03 6000 0.02 4578

1:1

4578

7000 2 0.06 14000 0.04 5341  1:1  10682

7500 2 0.06 15000 0.04 5723 1:1  11446

8000 3 0.10 24000 0.06 6104 1:1  18312

9000 192 6.21  1728000 4.43 6867  1:1  1318464

9500 2 0.06 19000 0.05 7249 1:1  14498

10000 5 0.16 50000 0.13 7630 1:1 38150

10500 1 0.03 10500 0.03 8012 1:1 8012

11500 1 0.03 11500 0.03 8775 1:1 8775

12000 1 0.03 12000 0.03 9156 1:1 9156

12500 1 0.03 12500 0.03 9538 1:1 9538

13500 2 0.06 27000 0.07  10301  1:1 20602

14000 1 0.03 14000 0.04 10682 1:1  10682

15000 4 0.13 60000 0.15 11445 1:1 45780

15500 1 0.03 15500 0.04 11827  1:1  11827 

16000 2 0.06 32000 0.08 12209 1:1 24418

18000 2003 64.82 36054000 92.47  13735 1:1 27511205

20000 1 0.03 20000 0.05 15260 1:1  15260

Total:  3090  100.00  38988500  100.00  29750366 

Page 4: Birla Medspa

8/6/2019 Birla Medspa

http://slidepdf.com/reader/full/birla-medspa 4/4

B. Allotment to Non Institutional Investors, including ASBA applications (After Technical Rejections) The basis of allotment to Non Institutional Investors, who have bid at the Issue Price of Rs.10/- per Equity Share, wasfinalized in consultation with BSE. The category was subscribed 0.16 times. The total number of equity sharesallotted in this category is 1614000 to 5 successful applicants. All the applicants in this category have been given firmallotment. There were five applications under ASBA process for 1614000 equity shares.

C. Allotment to QIBs (After Technical Rejections) 

The QIBs in this issue had 5 applications which were received through ASBA. The category was subscribed 1.03times. The total number of equity shares allotted in this category is 33812000 to 5 successful applicants. All theapplicants in this category have been given firm allotment.

Dates of dispatch of Refund Orders, Credit to beneficiary Accounts, Refund instructions and Listing details 

Activity  Date of Completion 

  Approval of Basis of Allotment by BSE June 30, 2011 

Dispatch of Allotment Advices, Refund Orders and ECS Intimation Note July 04, 2011 

Refund Instructions to the Clearing System (in case of Refunds through NECS system) July 04, 2011 

Instructions to the Self Certified Syndicate Banks (SCSBs) by the registrar July 01, 2011 

Listing Application to BSE July 04, 2011 

Credit to beneficiary Accounts July 02, 2011 

Refunds have been made through NECS into the Bank Accounts of the applicants, as registered with thedepositories. For other applicants Refund Orders have been dispatched to their address as registered with thedepositories. In case the same is not received within ten days, investors may contact at the address given below. TheRefund Orders have been over-printed with the Bank Mandate details as registered, if any, with the depositories. Theshares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of theaccount details with the depositories concerned. The company has obtained listing and trading permission fromBombay Stock Exchange Limited and trading in the equity shares of the company is expected to commence on 7thJuly2011.

INVESTORS PLEASE NOTEThis details of the allotment made would be hosted on the website of Registrars to the Issue, AdroitCorporate Services Private Limited at www.adroitcorporate.com